Public trial registry of the CCC-Munich

Trial DSHNHL 2009-1 (OPTIMAL>60)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
DSHNHL 2009-1 (OPTIMAL>60)
World
Full title
:

Improvement of Outcome and Reduction of Toxicity in Elderly Patients with CD20+ Aggressive B-Cell Lymphoma by Optimised Schedule of the Monoclonal Antibody Rituximab, Substitution of Conventional by Liposomal Vincristine, and FDG-PET based Reduction of Therapy intern unterbrochen REKRUTIERUNGNSENDE: LESS FAVOURABLE KOLLEKTIV

World
NCT number
:
NCT01478542
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Peter Herhaus 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier
Printer
 
Application_get